A CROSS-CULTURAL ANALYSIS OF SEX DIFFERENCES IN THE BEHAVIOR OF CHILDREN AGED THREE THROUGH 11WHITING B; POPE EDWARDS C.JOURNAL (THE) OF SOCIAL PSYCHOLOGY. 1973, Vol 91, Num 2, pp 171-187Article

DIGOXIN THERAPY: A CLINICAL PHARMACOKINETIC APPROACH.WHITING B.1978; SCOTT. MED. J.; G.B.; DA. 1978; VOL. 23; NO 1; PP. 50-53; BIBL. 11 REF.Article

THE MODELLING OF DRUG RESPONSEWHITING B; KELMAN AW.1980; CLIN. SCI. (1979); ISSN 0143-5221; GBR; DA. 1980; VOL. 59; NO 5; PP. 311-315; BIBL. 16 REF.Article

OPT: A PACKAGE OF COMPUTER PROGRAMS FOR PARAMETER OPTIMISATION IN CLINICAL PHARMACOKINETICSKELMAN AW; WHITING B; BRYSON SM et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 2; PP. 247-256; BIBL. 1 P.Article

THE INFLUENCE OF THEOPHYLLINE ON MAXIMAL RESPONSE TO SALBUTAMOL IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASEBARCLAY J; WHITING B; ADDIS GJ et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 5; PP. 389-393; BIBL. 11 REF.Article

DIGOXIN PHARMACOKINETICS: MULTICOMPARTMENTAL ANALYSIS AND ITS CLINICAL IMPLICATIONSSUMNER DJ; RUSSELL AJ; WHITING B et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 2; PP. 221-229; BIBL. 25 REF.Article

AN ASSESSMENT OF DIGOXIN RADIO-IMMUNOASSAY = EVALUATION DU DOSAGE RADIO-IMMUNOLOGIQUE DE LA DIGOXINEWHITING B; SUMNER DJ; GOLDBERG A et al.1973; SCOTT. MED. J.; G.B.; DA. 1973; VOL. 18; NO 3; PP. 69-74; BIBL. 25REF.Serial Issue

QUANTITATIVE ANALYSIS OF THE DISOPYRAMIDE CONCENTRATION-EFFECT RELATIONSHIPWHITING B; HOLFORD NHG; SHEINER LB et al.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 9; NO 1; PP. 67-75; BIBL. 6 REF.Article

Changing Life Styles in KenyaWHITING, B. B.Daedalus. Journal of the American Academy of Arts and Sciences Cambridge, Mass. 1977, Vol 106, Num 2, pp 211-225Article

DYSOPYRAMIDE PHARMACOKINETICS DURING RECOVERY FROM MYOCARDIAL INFARCTIONBRYSON SM; CAIRNS CJ; WHITING B et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 3; PP. 417-421; BIBL. 14 REF.Article

DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO THE ASSESSMENT OF BIOAVAILABILITYBRYSON SM; WHITING B; LAWRENCE JR et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 5; PP. 409-419; BIBL. 21 REF.Article

A PROCEDURE FOR MONITORING CYCLOPHOSPHAMIDE AND ISOPHOSPHAMIDE IN BIOLOGICAL SAMPLESWHITING B; MILLER SHK; CADDY B et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 4; PP. 373-376; BIBL. 3 REF.Article

ALTERATIONS OF PHENYTOIN PROTEIN BINDING WITH IN VIVO HAEMODIALYSIS IN DIALYSIS ENCEPHALOPATHYSTEELE WH; LAWRENCE JR; ELLIOTT HL et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 1; PP. 69-71; BIBL. 14 REF.Article

MEASUREMENT OF SYSTOLIC TIME INTERVALSKELMAN AW; SUMNER DJ; LAWRENCE JR et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 6; PP. 549-550; BIBL. 7 REF.Article

Quantum field theory and the antipodal identification of blackholesSANCHEZ, N; WHITING, B. F.Nuclear physics. B. 1987, Vol 283, Num 3-4, pp 605-623, issn 0550-3213Article

IS THE ACTION ON CYCLIC NUCLEOTIDES IMPORTANT FOR THE EFFECT OF "LOOP" DIURETICS.ELLIOTT HL; ANSARI AF; LAWRENCE JR et al.1979; DRUGS EXPER. CLIN. RES.; ESP; DA. 1979; VOL. 5; NO 1; PP. 51-56; BIBL. 19 REF.Article

HAEMODYNAMIC EFFECTS OF BM 10.188, A NEW ORALLY ACTIVE INOTROPIC AGENT, IN HEALTHY VOLUNTEERSWHITING B; KELMAN AW; SUMNER DJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982-02; VOL. 2; PP. 529-532; BIBL. 12 REF.Article

EFFECT OF NAPROXEN ONGLUCOSE METABOLISM AND TOLBUTAMIDE KINETICS AND DYNAMICS IN MATURITY ONSET DIABETICSWHITING B; WILLIAMS RL; LORENZI M et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 3; PP. 295-302; BIBL. 23 REF.Article

MODELING THEOPHYLLINE RESPONSE IN INDIVIDUAL PATIENTS WITH CHRONIC BRONCHITISWHITING B; KELMAN AW; BARCLAY J et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 4; PP. 481-487; BIBL. 12 REF.Article

THE APPLICATION OF HPLC TO THE DETERMINATION OF SOME 1,4 BENZODIAZEPINES AND THEIR METABOLITES IN PLASMA.SKELLERN GG; MEIER J; KNIGHT BI et al.1978; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1978; VOL. 5; NO 6; PP. 483-487; BIBL. 10 REF.Article

Bayesian parameter estimation and population pharmacokineticsTHOMSON, A. H; WHITING, B.Clinical pharmacokinetics. 1992, Vol 22, Num 6, pp 447-467, issn 0312-5963Article

THEOPHYLLINE-SALBUTAMOL INTERACTION: BRONCHODILATOR RESPONSE TO SALBUTAMOL AT MAXIMALLY EFFECTIVE PLASMA THEOPHYLLINE CONCENTRATIONSBARCLAY J; WHITING B; MEREDITH PA et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 2; PP. 203-208; BIBL. 10 REF.Article

EFFECT OF ACUTE ALCOHOL INTOXICATION ON THE METABOLISM AND PLASMA KINETICS OF CHLORDIAZEPOXIDEWHITING B; LAWRENCE JR; SKELLERN GG et al.1979; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1979; VOL. 7; NO 1; PP. 95-100; BIBL. 17 REF.Article

COMPUTER-ASSISTED REVIEW OF DIGOXIN THERAPY IN THE ELDERLY.WHITING B; WANDLESS I; SUMNER DJ et al.1978; BRIT. HEART J.; G.B.; DA. 1978; VOL. 40; NO 1; PP. 8-13; BIBL. 19 REF.Article

Page / 3